LDN-051 A NOVEL FECAL BIOMARKER FOR MONITORING DISEASE ACTIVITY AND THERAPEUTIC RESPONSE IN INFLAMMATORY BOWEL DISEASES – RESULTS OF A PHASE 2 CLINICAL TRIAL

Boldizsár Jójárt  ¹     Tamás Resál  ²     Diána Kata  ²     Tünde Molnár  ^{2, 3}     Péter Bacsur  ³     Viktória Szabó  ^{2, 3, 4}     Arpad Varga  ^{2, 3, 4}     Kata Szántó  ⁴     Imre Földesi  ⁴     Tamás Molnár  ⁴     József Maléth  ^{1, 2, 3, 5}     Klaudia Farkas  ^5    
1 Ladon Therapeutics Ltd, Szeged, Hungary
² University of Szeged, Szent-Györgyi Albert Medical School, Szeged, Hungary
³ ELKH-USz Momentum Epithelial Cell Signaling and Secretion Research Group, Szeged, Hungary
⁴ HCEMM-USz Molecular Gastroenterology Research Group, Szeged, Hungary
⁵ HCEMM-USz Molecular Gastroenterology Re

Topic
IBD

Session
Emerging aspects in pathogenesis and treatment of IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)